PD-L1 expressed from tumor cells promotes tumor growth and invasion in lung cancer via modulating TGF-β1/SMAD4 expression

Chia Nan University of Pharmacy & Science Institutional Repository > 環境永續暨休閒學院 > 運動管理系 > 期刊論文 > Item 310902800/34706

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34706

標題:	PD-L1 expressed from tumor cells promotes tumor growth and invasion in lung cancer via modulating TGF-β1/SMAD4 expression
作者:	Chen, Ming-Jenn Wang, Yao-Chen Wang, Lee Shen, Ching-Ju Chen, Chih-Yi Lee, Huei
貢獻者:	Chi Mei Hospital Department of Sports Management, Chia Nan University of Pharmacy & Science Chung Shan Medical University Chung Shan Medical University Hospital Chung Shan Medical University Kaohsiung Medical University Kaohsiung Medical University Hospital Chung Shan Medical University Chung Shan Medical University Hospital Taipei Medical University
關鍵字:	16/18 e6 oncoprotein human-papillomavirus b7-h1 expression infiltrating lymphocytes clinical-significance egfr mutations carcinoma survival overexpression progression
日期:	2022
上傳時間:	2023-12-11 14:06:15 (UTC+8)
出版者:	WILEY
摘要:	Background Programmed death ligand-1 (PD-L1) has a known association with the prognosis of human cancers because of its ability to alter tumor immune surveillance via its interaction with PD-1. We questioned whether expression of PD-L1 in tumor cells could directly promote tumor growth and invasiveness in non-small cell lung cancer (NSCLC). Methods Real-time reverse transcription-polymerase chain reaction (RT-PCR) was performed to evaluate PD-L1 messenger RNA (mRNA) expression in lung tumors. The prognostic value of PD-L1 mRNA was assessed by Cox regression model. Transcriptional regulation of PD-L1 by human papillomavirus (HPV) 16/18 E6 oncoprotein or by epidermal growth factor receptor (EGFR) mutation in lung cancer cells was examined by Western blot and luciferase reporter assay. The cell growth and invasion were evaluated by colony formation, soft agar growth, and Boyden chamber assay. Results The PD-L1 mRNA levels showed a positive association with HPV 16/18 E6 oncoprotein and with EGFR mutation in 223 surgically resected NSCLC patients. The prognostic significance of PD-L1 was more commonly observed in patients with high PD-L1/E6 positive and high PD-L1/EGFR mutant tumors. Mechanistically, upregulation of PD-L1 transcription by E6 or mutant EGFR occurred largely through the ERK-C/EBP beta-TLR4-NF-kappa B cascade. PD-L1 promotes the efficacy of colony formation, soft agar growth, and cell invasion. PD-L1 upregulates BAG-1 to reduce transforming growth factor (TGF)-beta 1 expression, and the decrease in SMAD4 because of TGF-beta 1 occurs through the p53/microRNA (miR)-224 axis. The decreases in TGF-beta 1 and SMAD4 are responsible for PD-L1-mediated cell invasiveness. Conclusion Induction of PD-L1 by E6 oncoprotein or mutant EGFR through the ERK-C/EBP beta-TLR4-NF-kappa B cascade may promote tumor growth and invasiveness in NSCLC because of decreasing TGF-beta 1 and SMAD4 expression.
關聯:	THORACIC CANCER, v.13, pp.1322–1332
顯示於類別:	[運動管理系] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
1759-7714.14388.pdf		4034Kb	Adobe PDF	64	檢視/開啟
index.html		0Kb	HTML	221	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....